Bioventus News

Bioventus | 8-K: Bioventus Reports First Quarter Financial Results

May 7 07:34 ET

Bioventus | DEFA14A: Others

Apr 26 07:43 ET

Bioventus | DEF 14A: Definitive information statements

Apr 26 07:43 ET

Bioventus | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Apr 10 16:13 ET

Bioventus | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 20 16:15 ET

Bioventus | 8-K: Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results

Mar 12 07:47 ET

Bioventus | 8-K: Current report

Jan 19 00:00 ET

Bioventus | 8-K: Current report

Jan 12 00:00 ET

Bioventus | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Jan 9 00:00 ET

Bioventus | 8-K: Current report

Dec 21, 2023 08:00 ET

Bioventus | 8-K: Bioventus Reports Third Quarter Financial Results; Raises Full Year 2023 Financial Guidance

Nov 7, 2023 07:35 ET

Bioventus | 8-K: Bioventus Reports Second Quarter Financial Results; Introduces Full Year 2023 Financial Guidance

Aug 8, 2023 08:02 ET

Bioventus | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Jun 16, 2023 16:56 ET

Bioventus | 8-K: Current report

Jun 9, 2023 17:04 ET

Bioventus | 8-K: Current report

May 26, 2023 08:39 ET

Bioventus | 8-K: Bioventus Reports First Quarter Financial Results

May 16, 2023 16:25 ET

Bioventus | 8-K: Current report

May 16, 2023 08:15 ET

Bioventus | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB

May 11, 2023 16:59 ET

Bioventus | 8-K: Current report

May 11, 2023 08:56 ET

Bioventus | DEFA14A: Others

Apr 27, 2023 08:45 ET